Juan C Hernandez-Boluda
Overview
Explore the profile of Juan C Hernandez-Boluda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mosquera-Orgueira A, Arellano-Rodrigo E, Garrote M, Martin I, Perez-Encinas M, Gomez-Casares M, et al.
Hemasphere
. 2024 Mar;
8(3):e60.
PMID: 38510992
No abstract available.
2.
Hernani R, Pinana J, Perez A, Quintero A, Montoro J, Hernandez-Boluda J, et al.
EJHaem
. 2022 Jul;
2(2):236-248.
PMID: 35845283
Sirolimus has emerged as an alternative to calcineurin inhibitors-based (CNI) graft-versus-host disease (GVHD) prophylaxis. This retrospective study compares the outcome of 133 consecutive adult patients with haematological malignancies undergoing haploidentical...
3.
Garcia-Fortes M, Hernandez-Boluda J, Alvarez-Larran A, Raya J, Angona A, Estrada N, et al.
Cancers (Basel)
. 2022 May;
14(9).
PMID: 35565461
The comorbidity burden is an important risk factor for overall survival (OS) in several hematological malignancies. This observational prospective study was conducted to evaluate the impact of individual comorbidities on...
4.
Bueno F, Albert E, Gimenez E, Pinana J, Perez A, Gomez M, et al.
J Med Virol
. 2021 Feb;
93(8):4773-4779.
PMID: 33605457
It is uncertain whether gastrointestinal (GI) infection caused by viral and bacterial pathogens may predispose to gastrointestinal acute Graft-versus-host disease (aGvHD-GI) in allogeneic hematopoietic stem cell transplant recipients (allo-HSCT). We...
5.
Montoro J, Pinana J, Hernandez-Boluda J, Hernani R, Lorenzo I, Perez A, et al.
Bone Marrow Transplant
. 2020 May;
55(11):2147-2159.
PMID: 32371901
Following the success of posttransplant cyclophosphamide (PT-CY) as graft-versus-host disease (GVHD) prophylaxis in haploidentical transplantation, this prevention strategy has progressively been used for allogeneic hematopoietic stem cell transplantation (allo-HSCT) from...
6.
Masarova L, Mesa R, Hernandez-Boluda J, Taylor J
Leuk Res
. 2020 Mar;
91:106338.
PMID: 32200188
No abstract available.
7.
Sanz J, Montoro J, Solano C, Valcarcel D, Sampol A, Ferra C, et al.
Biol Blood Marrow Transplant
. 2019 Oct;
26(2):358-366.
PMID: 31655119
In this prospective randomized study, we compared the outcomes of single-unit umbilical cord blood transplantation (UCBT) and unmanipulated haploidentical stem cell transplantation (haplo-SCT) with post-transplantation cyclophosphamide (PTCy) in adults with...
8.
Perez-Pitarch A, Guglieri-Lopez B, Ferriols-Lisart R, Perez A, Ezquer-Garin C, Hernandez-Boluda J, et al.
Ther Drug Monit
. 2019 May;
41(6):740-747.
PMID: 31136417
Background: To evaluate the adequacy of different dosing regimens of voriconazole for the prophylaxis of invasive candidiasis and aspergillosis in adult allogeneic stem cell transplant recipients by means of population...
9.
Pascual T, Solano C, Torres I, Talaya A, Gimenez E, Vinuesa V, et al.
J Med Virol
. 2018 Apr;
90(8):1375-1382.
PMID: 29663435
Preemptive antiviral therapy based on detecting cytomegalovirus (CMV) DNAemia above a preestablished threshold is the mainstay strategy for the prevention of CMV disease in allogeneic hematopoietic stem cell transplant (allo-HSCT)...
10.
Garcia-Gutierrez V, Gomez-Casares M, Puerta J, Alonso-Dominguez J, Osorio S, Hernandez-Boluda J, et al.
PLoS One
. 2017 Mar;
12(3):e0173532.
PMID: 28278193
In chronic myeloid leukemia (CML) patients, 3-month BCR-ABL1 levels have consistently been correlated with further outcomes. Monitoring molecular responses in CML using the GeneXpert (Cepheid) platform has shown an optimal...